In the ATTAIN-1 clinical study, adults with obesity or overweight and a weight-related health condition, but without diabetes, took Foundayo alongside healthy eating and physical activity for 72 weeks.
People receiving the highest dose lost an average of around 11% of their starting body weight when all participants were included, whether or not they completed treatment exactly as planned. When looking at people who continued treatment as planned, average weight loss was around 12%.
Some people lost considerably more, while others lost less. Your results will depend on factors including your dose, how consistently you take the medicine, side effects, diet, activity, sleep, other health conditions and your individual response to treatment.